These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 21496949)

  • 21. Hyperreactivity of pseudoxanthoma elasticum-affected dermis to vitamin D3.
    Hamamoto Y; Nagai K; Yasui H; Muto M
    J Am Acad Dermatol; 2000 Apr; 42(4):685-7. PubMed ID: 10727321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study.
    Qunibi W; Moustafa M; Muenz LR; He DY; Kessler PD; Diaz-Buxo JA; Budoff M;
    Am J Kidney Dis; 2008 Jun; 51(6):952-65. PubMed ID: 18423809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral warning signs of elastic pseudoxanthoma.
    Alvim LP; Pires TI; Chaves MD; Savioli C; Fabri GM
    Womens Health (Lond); 2016 Sep; 12(5):492-495. PubMed ID: 27634974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sevelamer versus calcium carbonate in incident hemodialysis patients: results of an open-label 24-month randomized clinical trial.
    Di Iorio B; Molony D; Bell C; Cucciniello E; Bellizzi V; Russo D; Bellasi A;
    Am J Kidney Dis; 2013 Oct; 62(4):771-8. PubMed ID: 23684755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lansoprazole Increases Inorganic Pyrophosphate in Patients with Pseudoxanthoma Elasticum: A Double-Blind, Randomized, Placebo-Controlled Crossover Trial.
    Murcia Casas B; Carrillo Linares JL; Baquero Aranda I; Rioja Villodres J; Merino Bohórquez V; González Jiménez A; Rico Corral MÁ; Bosch R; Sánchez Chaparro MÁ; García Fernández M; Valdivielso P
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pseudoxanthoma elasticum.
    Buteică E; Stoicescu I; Burada F; Ioana M; Roşulescu E; Enescu A; Niculescu EC; Buteică SA; Stănoiu B
    Rom J Morphol Embryol; 2008; 49(4):563-7. PubMed ID: 19050808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of efficacy of the phosphate binders nicotinic acid and sevelamer hydrochloride in hemodialysis patients.
    Ahmadi F; Shamekhi F; Lessan-Pezeshki M; Khatami MR
    Saudi J Kidney Dis Transpl; 2012 Sep; 23(5):934-8. PubMed ID: 22982903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment with phosphate binder (sevelamer hydrochloride, calcium carbonate) based on PTH].
    Sato M; Fukazawa S; Yasuda T; Akatsuka T; Tozawa S; Niida Y; Hashimoto N; Mochizuki T; Koike T
    Clin Calcium; 2005 Sep; 15 Suppl 1():23-8; discussion 28-9. PubMed ID: 16272625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibroblasts from patients affected by Pseudoxanthoma elasticum exhibit an altered PPi metabolism and are more responsive to pro-calcifying stimuli.
    Boraldi F; Annovi G; Bartolomeo A; Quaglino D
    J Dermatol Sci; 2014 Apr; 74(1):72-80. PubMed ID: 24461675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of gastric acid suppression with pantoprazole on the efficacy of sevelamer hydrochloride as a phosphate binder in haemodialysis patients: a pilot study.
    Lai B; Cervelli MJ
    Nephrology (Carlton); 2012 May; 17(4):402-6. PubMed ID: 22329674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pseudoxanthoma elasticum-like fibers in the inflamed skin of patients without pseudoxanthoma elasticum.
    Bowen AR; Götting C; LeBoit PE; McCalmont TH
    J Cutan Pathol; 2007 Oct; 34(10):777-81. PubMed ID: 17880583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The placenta in pseudoxanthoma elasticum: clinical, structural and immunochemical study.
    Gheduzzi D; Taparelli F; Quaglino D; Di Rico C; Bercovitch L; Terry S; Singer DB; Pasquali-Ronchetti I
    Placenta; 2001 Jul; 22(6):580-90. PubMed ID: 11440547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of sevelamer hydrochloride and calcium acetate in patients on peritoneal dialysis.
    Evenepoel P; Selgas R; Caputo F; Foggensteiner L; Heaf JG; Ortiz A; Kelly A; Chasan-Taber S; Duggal A; Fan S
    Nephrol Dial Transplant; 2009 Jan; 24(1):278-85. PubMed ID: 18820280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dermoscopic features of pseudoxanthoma elasticum.
    Kawashima S; Togawa Y; Miyachi H; Matsue H
    Clin Exp Dermatol; 2018 Mar; 43(2):175-179. PubMed ID: 29271496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variants in genes encoding pyrophosphate metabolizing enzymes are associated with Pseudoxanthoma elasticum.
    Dabisch-Ruthe M; Brock A; Kuzaj P; Charbel Issa P; Szliska C; Knabbe C; Hendig D
    Clin Biochem; 2014 Oct; 47(15):60-7. PubMed ID: 25025693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pseudoxanthoma elasticum-like lesions in association with thalassaemia major.
    Yu S; Ming A; Wegman A
    Australas J Dermatol; 2009 Aug; 50(3):186-9. PubMed ID: 19659980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose-finding study of bixalomer in patients with chronic kidney disease on hemodialysis with hyperphosphatemia: a double-blind, randomized, placebo-controlled and sevelamer hydrochloride-controlled open-label, parallel group study.
    Akizawa T; Origasa H; Kameoka C; Kaneko Y; Kanoh H
    Ther Apher Dial; 2014 Jun; 18 Suppl 2():24-32. PubMed ID: 24975892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between the distribution of pseudoxanthoma elasticum skin and mucous membrane lesions and cardiovascular involvement.
    Utani A; Tanioka M; Yamamoto Y; Taki R; Araki E; Tamura H; Miyachi Y
    J Dermatol; 2010 Feb; 37(2):130-6. PubMed ID: 20175846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pseudoxanthoma elasticum: description of a late onset case.
    Baglieri F; Scuderi G
    Indian J Dermatol Venereol Leprol; 2010; 76(4):448. PubMed ID: 20657146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of pseudoxanthoma elasticum with tocopherol acetate and ascorbic acid.
    Takata T; Ikeda M; Kodama H; Kitagawa N
    Pediatr Dermatol; 2007; 24(4):424-5. PubMed ID: 17845175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.